Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Top ETF of December & Its Best Stocks
12:03pm, Thursday, 24'th Dec 2020
We have highlighted the best ETF of December and its best performing stocks.
Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options
09:47am, Wednesday, 23'rd Dec 2020
Investors need to pay close attention to Pacific Biosciences (PACB) stock based on the movements in the options market lately.
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:05pm, Friday, 18'th Dec 2020
MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequen
Why BioCardia, Pacific Biosciences And HCA Are Trading Higher Today
12:23pm, Monday, 14'th Dec 2020
BioCardia (NASDAQ: BCDA) shares are trading higher. The company said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Tr
Why You Should Retain Pacific Biosciences (PACB) Stock Now
12:15pm, Thursday, 03'rd Dec 2020
Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects.
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
12:21am, Wednesday, 11'th Nov 2020
MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its pre
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
04:05pm, Tuesday, 10'th Nov 2020
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common sto
Why Pacific Biosciences of California Hit a Speed Bump With Its Q3 Results
06:15am, Tuesday, 03'rd Nov 2020
The COVID-19 pandemic continues to negatively impact the gene-sequencing company's sales.
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q3 2020 Results - Earnings Call Transcript
11:14pm, Monday, 02'nd Nov 2020
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q3 2020 Results - Earnings Call Transcript
Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates
06:15pm, Monday, 02'nd Nov 2020
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0.00% and -6.46%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results
04:02pm, Monday, 02'nd Nov 2020
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020.
Why Pacific Biosciences of California Stock Jumped Today | The Motley Fool
07:37pm, Friday, 02'nd Oct 2020
Investors are enthusiastic about an analyst's upgrade of the stock.
New Leadership Driving New Interest In Pacific Biosciences (NASDAQ:PACB)
01:52pm, Wednesday, 23'rd Sep 2020
Pacific Biosciences' new CEO Christian Henry has made it clear that he intends to drive significant investment in the company's commercialization efforts.
Track fault delays evening service on East-West Line between Pasir Ris and Aljunied
12:35pm, Tuesday, 15'th Sep 2020
SINGAPORE - The train service from Aljunied towards Pasir Ris on the East-West Line (EWL) was disrupted for close to 50 minutes on Tuesday (Sept 15) evening.. Read more at straitstimes.com.
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
03:50pm, Friday, 04'th Sep 2020
Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
